ThromboGenics

ThromboGenics

ThromboGenics

Delivering next gen treatments for vitreo-retinal disorders, focus on diabetic eye disease. Pioneering pharmacological vitreolysis globally (ocriplasmin owner).
Follow us
Alexa global traffic share